https://www.zonebourse.com/cours/action/INCYTE-CORPORATION-9675/actualite/Incyte-annonce-que-sa-demande-d-indication-supplementaire-sNDA-pour-la-creme-au-ruxolitinib-O-37339065/?utm_source=telegram&utm_medium=social&utm_campaign=share